As mentioned in the review, the activation of the TRPV2 by its cannabidiol increases the cellular uptake of doxorubicin, which enhances the sensitivity of breast cancer cells to chemotherapy in vitro and in vivo. This evidence concerns the gene TRPV2 and breast cancer.